Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

R-Tech Ueno, Ltd. — Sucampo Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / R-Tech Ueno, Ltd.

R-Tech Ueno, Ltd.

10% owner at Sucampo Pharmaceuticals, Inc. · on record since Aug 7, 2007

Insider trading activity of R-Tech Ueno, Ltd.

Transactions on record: 1; since Aug 7, 2007

Open-market buys: 0

Open-market sells: 1; $6.7M

Companies traded: 1; last filing Aug 7, 2007

Figures computed from official regulatory filings — methodology.

Companies where R-Tech Ueno, Ltd. has traded

Sucampo Pharmaceuticals, Inc.1 tx · $6.7M · Aug 7, 2007

Track record of R-Tech Ueno, Ltd.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of R-Tech Ueno, Ltd.

Co-insiders of R-Tech Ueno, Ltd.

Alder MatthiasSucampo Pharmaceuticals, Inc.
Ashton WilliamSucampo Pharmaceuticals, Inc.
Astellas Pharma Inc.Sucampo Pharmaceuticals, Inc.
Bryan Jones W.Sucampo Pharmaceuticals, Inc.
Celeste Anthony C.Sucampo Pharmaceuticals, Inc.
Claiborne Cary JSucampo Pharmaceuticals, Inc.
Dolecek Gayle RSucampo Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Donley Matthew MaxwellSucampo Pharmaceuticals, Inc.

Driggs AlexSucampo Pharmaceuticals, Inc.

Edick Paul RSucampo Pharmaceuticals, Inc.

Egan JamesSucampo Pharmaceuticals, Inc.

Fackler Brad ESucampo Pharmaceuticals, Inc.

FERRARA ANDREW JSucampo Pharmaceuticals, Inc.

Getman Daniel PSucampo Pharmaceuticals, Inc.

Greenleaf PeterSucampo Pharmaceuticals, Inc.

Hrushka Charles SSucampo Pharmaceuticals, Inc.

JEFFRIES MICHAEL JSucampo Pharmaceuticals, Inc.

Johnson John HSucampo Pharmaceuticals, Inc.

KAISER RONALD WSucampo Pharmaceuticals, Inc.

Kiener Peter ASucampo Pharmaceuticals, Inc.

Knapp Thomas JSucampo Pharmaceuticals, Inc.

Kuno SachikoSucampo Pharmaceuticals, Inc.

Lichtlen PeterSucampo Pharmaceuticals, Inc.

MAUDLIN TIMOTHY ISucampo Pharmaceuticals, Inc.

Meyenburg Jason PatrickSucampo Pharmaceuticals, Inc.

Miele Stanley GSucampo Pharmaceuticals, Inc.

Mine HidetoshiSucampo Pharmaceuticals, Inc.

Molina V SueSucampo Pharmaceuticals, Inc.

Morris Mariam ESucampo Pharmaceuticals, Inc.

MUNDER BARBARA ASucampo Pharmaceuticals, Inc.

Nantahala Capital Management, LLCSucampo Pharmaceuticals, Inc.

OCONNELL MAUREENSucampo Pharmaceuticals, Inc.

OPE Limited Partnership 2Sucampo Pharmaceuticals, Inc.

ORIX CORPSucampo Pharmaceuticals, Inc.

PFREUNDSCHUH PETER P.Sucampo Pharmaceuticals, Inc.

Ridgeway Capital Partners LTDSucampo Pharmaceuticals, Inc.

Smilek JanSucampo Pharmaceuticals, Inc.

Smith Andrew PSucampo Pharmaceuticals, Inc.

Smith Karen L.Sucampo Pharmaceuticals, Inc.

Spiegel Robert J.Sucampo Pharmaceuticals, Inc.

S&R Technology Holdings, LLCSucampo Pharmaceuticals, Inc.

Tolliver Kei SSucampo Pharmaceuticals, Inc.

Ueno RyujiSucampo Pharmaceuticals, Inc.

Walbert Timothy PSucampo Pharmaceuticals, Inc.

WRIGHT JOHN CSucampo Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Sucampo Pharmaceuticals, Inc.	Aug 7, 2007	Sell	-625,000	10.70	$6.7M	SEC